z-logo
Premium
5q14.3 neurocutaneous syndrome: A novel continguous gene syndrome caused by simultaneous deletion of RASA1 and MEF2C
Author(s) -
Carr Christopher W.,
Zimmerman Holly H.,
Martin Christa Lese,
Vikkula Miikka,
Byrd Adam C.,
AbdulRahman Omar A.
Publication year - 2011
Publication title -
american journal of medical genetics part a
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.064
H-Index - 112
eISSN - 1552-4833
pISSN - 1552-4825
DOI - 10.1002/ajmg.a.34059
Subject(s) - haploinsufficiency , mef2c , etiology , microdeletion syndrome , medicine , genetics , chromosome , neuroscience , biology , gene , phenotype , pathology , gene expression
Haploinsufficiency of RASA1 , located on chromosome 5q14.3, has been identified as the etiology underlying the disorder capillary malformation–arteriovenous malformation (CM–AVM). Recently, haploinsufficiency of MEF2C , located 1.33 Mb distal to RASA1 on chromosome 5q14.3, has been implicated as the genetic etiology underlying a complex array of deficits including mental retardation, hypotonia, absent speech, seizures, and brain anomalies. Here we report a patient who is haploinsufficient in both RASA1 and MEF2C who presents with dermatologic and neurologic abnormalities that constitute a 5q14.3 neurocutaneous syndrome. This finding highlights the need to assess for CM–AVM in patients with neurologic features consistent with MEF2C haploinsufficiency, and vice versa. © 2011 Wiley‐Liss, Inc.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom